<VariationArchive VariationID="984632" VariationName="NM_005859.5(PURA):c.534_556dup (p.Gln186fs)" VariationType="Duplication" Accession="VCV000984632" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2020-11-14" MostRecentSubmission="2020-11-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="972716" VariationID="984632">
      <GeneList>
        <Gene Symbol="PURA" FullName="purine rich element binding protein A" GeneID="5813" HGNC_ID="HGNC:9701" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114109" stop="140125619" display_start="140114109" display_stop="140125619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139493707" stop="139499000" display_start="139493707" display_stop="139499000" Strand="+" />
          </Location>
          <OMIM>600473</OMIM>
          <Haploinsufficiency last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005859.5(PURA):c.534_556dup (p.Gln186fs)</Name>
      <CanonicalSPDI>NC_000005.10:140114709:GGGCCTGGCCTGGGCTCCACGCAGGGCC:GGGCCTGGCCTGGGCTCCACGCAGGGCCTGGCCTGGGCTCCACGCAGGGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114709" stop="140114710" display_start="140114709" display_stop="140114710" variantLength="23" positionVCF="140114709" referenceAlleleVCF="G" alternateAlleleVCF="GGGGCCTGGCCTGGGCTCCACGCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139494294" stop="139494295" display_start="139494294" display_stop="139494295" variantLength="23" positionVCF="139494294" referenceAlleleVCF="G" alternateAlleleVCF="GGGGCCTGGCCTGGGCTCCACGCA" />
      </Location>
      <ProteinChange>Q186fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.140114715_140114737dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.140114715_140114737dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.139494300_139494322dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.139494300_139494322dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041813.1" sequenceAccession="NG_041813" sequenceVersion="1" change="g.5593_5615dup">
            <Expression>NG_041813.1:g.5593_5615dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.5" sequenceAccession="NM_005859" sequenceVersion="5" change="c.534_556dup" MANESelect="true">
            <Expression>NM_005859.5:c.534_556dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005850.1" sequenceAccession="NP_005850" sequenceVersion="1" change="p.Gln186fs">
            <Expression>NP_005850.1:p.Gln186fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1763049807" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005859.5(PURA):c.534_556dup (p.Gln186fs) AND PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" Accession="RCV001264732" Version="1">
        <ClassifiedConditionList TraitSetID="20405">
          <ClassifiedCondition DB="MedGen" ID="C4015357">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-06-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-06-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-11-14" MostRecentSubmission="2020-11-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="20405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32585" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ElementValue>
                <XRef ID="MONDO:0018580" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDRIHF</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurologic Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PURA-related neurodevelopmental disorders include PURA syndrome, caused by a heterozygous pathogenic sequence variant in PURA, and 5q31.3 deletion syndrome, caused by a genomic 5q31.3 deletion encompassing all or part of PURA.
PURA-related neurodevelopmental disorders are characterized by moderate-to-severe neurodevelopmental delay with absence of speech in most and lack of independent ambulation in many. Early-onset problems can include hypotonia, hypothermia, hypersomnolence, feeding difficulties, excessive hiccups, recurrent central and obstructive apneas, epileptic seizures, abnormal nonepileptic movements (dystonia, dyskinesia, and dysconjugate eye movements), and abnormal vision. Congenital heart defects, urogenital malformations, skeletal abnormalities, and endocrine disorders occur, but are less common.</Attribute>
                <XRef ID="NBK426063" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurodevelopmental Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28448108</ID>
                <ID Source="BookShelf">NBK426063</ID>
              </Citation>
              <XRef ID="438213" DB="Orphanet" />
              <XRef ID="438216" DB="Orphanet" />
              <XRef ID="C4015357" DB="MedGen" />
              <XRef Type="MIM" ID="616158" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2848963" SubmissionDate="2020-11-06" DateLastUpdated="2020-11-14" DateCreated="2020-11-14">
        <ClinVarSubmissionID localKey="NM_005859.4:c.534_556dup|OMIM:616158" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001442963" DateUpdated="2020-11-14" DateCreated="2020-11-14" Type="SCV" Version="1" SubmitterName="Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine" OrgID="506968" OrganizationCategory="laboratory" OrgAbbreviation="LABOGENMOL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005859.4:c.534_556dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616158" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8478274</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2848963" TraitType="Disease" MappingType="XRef" MappingValue="616158" MappingRef="OMIM">
        <MedGen CUI="C4015357" Name="PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

